{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:55:01Z","timestamp":1761519301019,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.canrad.2019.12.002","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T19:39:05Z","timestamp":1584041945000},"page":"298-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure"],"prefix":"10.1016","volume":"24","author":[{"given":"A.","family":"Mousli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bihin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Koerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mouchamps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Daisne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2019.12.002_bib0155","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2019.12.002_bib0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1200\/JCO.2017.75.9589","article-title":"Whole-brain radiotherapy for brain metastases: evolution or revolution?","volume":"36","author":"Brown","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0165","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","article-title":"Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial","volume":"280","author":"Patchell","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2019.12.002_bib0170","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0175","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2019.12.002_bib0180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-6-48","article-title":"Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0190","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ijrobp.2013.03.037","article-title":"Multidose stereotactic radiosurgery (9Gy\u00d73) of the postoperative resection cavity for treatment of large brain metastases","volume":"86","author":"Minniti","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2019.12.002_bib0195","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijrobp.2013.09.051","article-title":"A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases","volume":"88","author":"Brennan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2019.12.002_bib0200","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0205","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1227\/01.NEU.0000360391.35749.A5","article-title":"T1\/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery","volume":"66","author":"Kano","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2019.12.002_bib0210","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1227\/NEU.0b013e31826909f2","article-title":"Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis","volume":"71","author":"Robbins","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2019.12.002_bib0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijrobp.2007.06.068","article-title":"Stereotactic radiosurgery of the postoperative resection cavity for brain metastases","volume":"70","author":"Soltys","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2019.12.002_bib0220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1227\/NEU.0b013e31827fcd60","article-title":"The role of radiosurgery to the tumor bed after resection of brain metastases","volume":"72","author":"Gans","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2019.12.002_bib0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1748-717X-8-135","article-title":"Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation","volume":"8","author":"Eaton","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0230","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.adro.2017.07.006","article-title":"Fractionated stereotactic radiation therapy for intact brain metastases","volume":"2","author":"Marcrom","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0235","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.radonc.2011.01.011","article-title":"Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review","volume":"98","author":"Wiggenraad","year":"2011","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0240","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/neuonc\/now301","article-title":"The radiosurgery fractionation quandary: single fraction or hypofractionation?","volume":"19","author":"Kirkpatrick","year":"2017","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0245","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.canrad.2017.04.014","article-title":"D\u00e9lin\u00e9ation du lit op\u00e9ratoire des m\u00e9tastases c\u00e9r\u00e9brales op\u00e9r\u00e9es trait\u00e9es par irradiation en conditions st\u00e9r\u00e9otaxiques adjuvante\u00a0: revue de la litt\u00e9rature","volume":"21","author":"Keller","year":"2017","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2019.12.002_bib0250","first-page":"4","article-title":"Stereotactic radiotherapy following surgery for brain metastasis: predictive factors for local control and radionecrosis","volume":"21","author":"Dor\u00e9","year":"2017","journal-title":"Cancer Radiother J Soc Francaise Radiother Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0255","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.canrad.2017.01.017","article-title":"Risque de radion\u00e9crose apr\u00e8s radioth\u00e9rapie hypofractionn\u00e9e en conditions st\u00e9r\u00e9otaxiques du lit op\u00e9ratoire de m\u00e9tastases c\u00e9r\u00e9brales","volume":"21","author":"Keller","year":"2017","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2019.12.002_bib0260","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijrobp.2017.09.047","article-title":"Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases","volume":"100","author":"Soliman","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2019.12.002_bib0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/neuros\/nyy146","article-title":"Preoperative vs postoperative radiosurgery for resected brain metastases: a review","volume":"84","author":"Prabhu","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2019.12.002_bib0270","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1227\/NEU.0000000000001096","article-title":"Comparing preoperative with postoperative stereotactic radiosurgery for resectable brain metastases: a multi-institutional analysis","volume":"79","author":"Patel","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2019.12.002_bib0275","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fonc.2017.00147","article-title":"Immunotherapy combined with large fractions of radiotherapy: stereotactic radiosurgery for brain metastases-implications for intraoperative radiotherapy after resection","volume":"7","author":"Herskind","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0280","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1200\/JCO.2011.40.1174","article-title":"trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer","volume":"31","author":"Welsh","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0285","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2019.12.002_bib0290","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.1200\/JCO.2017.35.15_suppl.9508","article-title":"A randomized phase II study of nivolumab or nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases (mets): The Anti-PD1 Brain Collaboration (ABC)","volume":"35","author":"Long","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2019.12.002_bib0295","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ijrobp.2016.01.037","article-title":"Impact of deferring radiation therapy in patients with epidermal growth factor receptor-mutant non-small cell lung cancer who develop brain metastases","volume":"95","author":"Magnuson","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2019.12.002_bib0300","doi-asserted-by":"crossref","first-page":"E102","DOI":"10.1016\/j.ijrobp.2015.07.807","article-title":"Concurrent immunotherapy and stereotactic radiosurgery for brain metastases is associated with a decreased incidence of new intracranial metastases","volume":"93","author":"Chen","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820300445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820300445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:31:17Z","timestamp":1761136277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321820300445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1278321820300445"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2019.12.002","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2019.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}